{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:52:18Z","timestamp":1794279138314,"version":"4.9.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001840","name":"Icelandic Center of Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001840","id-type":"DOI","asserted-by":"crossref"}]},{"name":"(RANN\u00cdS)"},{"DOI":"10.13039\/501100005415","name":"University of Iceland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005415","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ijpharm.2014.08.013","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T12:32:16Z","timestamp":1407933136000},"page":"80-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Effect of \u03b3-cyclodextrin on solubilization and complexation of irbesartan: Influence of pH and excipients"],"prefix":"10.1016","volume":"474","author":[{"given":"Chutimon","family":"Muankaew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phatsawee","family":"Jansook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar","family":"Stef\u00e1nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsteinn","family":"Loftsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2014.08.013_bib0005","first-page":"228","article-title":"2-Hydroxypropyl-\u03b2-cyclodextrin complex with ketotifen fumarate for eye drops preparations","volume":"3","author":"Abd El-Bary","year":"2011","journal-title":"Int. J. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0010","series-title":"Cyclodextrins as Bioavailability Enhancers","first-page":"45","author":"Acarturk","year":"2011"},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0015","first-page":"780","article-title":"Solid dispersions \u2013 an approach to enhance the dissolution rate of irbesartan","volume":"1","author":"Aruna","year":"2011","journal-title":"Int. J. Res. Pharm. Chem."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0020","series-title":"Influence of Water-Soluble Polymers, pH and Surfactants on Mebendazole (MBZ) Solubilization by \u03b2-and Partially Methylated-\u03b2-cyclodextrins","first-page":"386","author":"Ba","year":"2008"},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0025","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/la052878f","article-title":"Self-assembly of \u03b2-cyclodextrin in water. Part 1: cryo-TEM and dynamic and static light scattering","volume":"22","author":"Bonini","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0030","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/ja9828657","article-title":"Interconnective host\u2013guest complexation of \u03b2-cyclodextrin-calix 4 arene couples","volume":"121","author":"B\u00fcgler","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2007.07.018","article-title":"The utility of cyclodextrins for enhancing oral bioavailability","volume":"123","author":"Carrier","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejps.2007.05.111","article-title":"A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug","volume":"32","author":"Chawla","year":"2007","journal-title":"Eur. J. Pharm. Sci"},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0050","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/01.hjh.0000220410.69116.f8","article-title":"Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: effects of blood pressure control and beyond","volume":"24","author":"Clermont","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jpba.2010.05.020","article-title":"Combined effect of polarity and pH on the chromatographic behavior of some angiotensin II receptor antagonists and optimization of their determination in pharmaceutical dosage forms","volume":"53","author":"Demiralay","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0060","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/03639045.2020.12098150","article-title":"Effect of water-soluble polymers on naproxen complexation with natural and chemically modified \u03b2-cyclodextrins","volume":"27","author":"Faucci","year":"2001","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0065","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1167\/iovs.11-9167","article-title":"Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels","volume":"53","author":"Fujita","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijpharm.2009.06.027","article-title":"Development of a new topical system drug-in-cyclodextrin-in-deformable liposome","volume":"380","author":"Gillet","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejpb.2011.01.011","article-title":"Skin penetration behaviour of liposomes as a function of their composition","volume":"79","author":"Gillet","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1023065823358","article-title":"The aggregation of cyclodextrins as studied by photon correlation spectroscopy","volume":"44","author":"Gonzalez-Gaitano","year":"2003","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0085","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1517\/17425247.2010.497536","article-title":"Promising complexes of acetazolamide for topical ocular administration","volume":"7","author":"Granero","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jop.2013.0060","article-title":"\u03b3-Cyclodextrin nanoparticle eye drops with dorzolamide: effect on intraocular pressure in man","volume":"30","author":"Gudmundsdottir","year":"2014","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0095","first-page":"117","article-title":"Phase-solubility techniques","volume":"4","author":"Higuchi","year":"1965","journal-title":"Advan. Anal. Chem. Instr."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1208\/s12249-009-9206-5","article-title":"Preformulation study of the inclusion complex irbesartan-\u03b2-cyclodextrin","volume":"10","author":"Hirlekar","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0105","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1208\/s12249-009-9274-6","article-title":"Studies on the effect of water-soluble polymers on drug\u2013cyclodextrin complex solubility","volume":"10","author":"Hirlekar","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0110","first-page":"2064","article-title":"Formulation of irbesartan by microcrystal technology for enhancing the solubility and dissolution properties","volume":"6","author":"Jain","year":"2013","journal-title":"Int. J. Pharm. Sci. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2009.06.005","article-title":"CDs as solubilizers effects of excipients and competing drugs","volume":"379","author":"Jansook","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10847-010-9779-3","article-title":"Effect of self-aggregation of \u03b3-cyclodextrin on drug solubilization","volume":"68","author":"Jansook","year":"2010","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejpb.2010.07.005","article-title":"Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension","volume":"76","author":"Jansook","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0130","doi-asserted-by":"crossref","DOI":"10.3109\/10837450.2014.910811","article-title":"Development of eye drops containing antihypertensive drugs: formulation of aqueous irbesartan\/\u03b3CD eye drops","author":"Jansook","year":"2014","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0135","doi-asserted-by":"crossref","DOI":"10.1089\/jop.2013.0164","article-title":"Dorzolamide cyclodextrin nanoparticle suspension eye drops and trusopt in rabbit","author":"Johannesson","year":"2014","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0140","article-title":"Kinetics of \u03b3-cyclodextrin nanoparticle suspension eye drops in tear fluid","author":"Johannesson","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(00)00359-8","article-title":"Formulation and evaluation of ophthalmic preparations of acetazolamide","volume":"199","author":"Kaur","year":"2000","journal-title":"Int. J. Pharm"},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0150","first-page":"4","article-title":"Developments and advanced approaches of ophthalmic drug delivery system: a review","volume":"5","author":"Kavitha","year":"2013","journal-title":"Int. J. Curr. Pharm. Res."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1208\/s12249-009-9205-6","article-title":"Drug targeting to the hair follicles: a cyclodextrin-based drug delivery","volume":"10","author":"Konradsdottir","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0160","first-page":"167","article-title":"Cyclodextrins","volume":"453","author":"Kurkov","year":"2013","journal-title":"Int. J. Pharm. (Amsterdam, Neth.)"},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF01066207","article-title":"Proton NMR spectroscopy as a probe of intermolecular interactions in \u03b2-cyclodextrin inclusion compounds","volume":"10","author":"Lehmann","year":"1991","journal-title":"J. Incl. Phenom. Mol. Recognit. Chem."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0170","doi-asserted-by":"crossref","DOI":"10.1007\/s10847-013-0375-1","article-title":"Self-assembled cyclodextrin nanoparticles and drug delivery","author":"Loftsson","year":"2013","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.10.044","article-title":"Cyclodextrins and their pharmaceutical applications","volume":"329","author":"Loftsson","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-5173(97)00371-2","article-title":"The effect of water-soluble polymers on the aqueous solubility and complexing abilities of \u03b2-cyclodextrin","volume":"163","author":"Loftsson","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2005.05.042","article-title":"Evaluation of cyclodextrin solubilization of drugs","volume":"302","author":"Loftsson","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0190","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10847-006-9247-2","article-title":"The complexation efficiency","volume":"57","author":"Loftsson","year":"2007","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0195","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1211\/jpp.59.5.0002","article-title":"Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops","volume":"59","author":"Loftsson","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1773-2247(04)50003-5","article-title":"The effects of water-soluble polymers on cyclodextrins and cyclodextrin solubilization of drugs","volume":"14","author":"Loftsson","year":"2004","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-5173(01)00895-X","article-title":"Cyclodextrins and drug permeability through semi-permeable cellophane membranes","volume":"232","author":"Loftsson","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-5173(03)00334-X","article-title":"The effects of organic salts on the cyclodextrin solubilization of drugs","volume":"262","author":"Loftsson","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0215","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.carbpol.2013.09.084","article-title":"Effect of HPMC concentration on \u03b2-cyclodextrin solubilization of norfloxacin","volume":"101","author":"Loh","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0220","first-page":"529","article-title":"A review on recent studies and advances in ocular drug delivery system","volume":"4","author":"Madhuri Divya","year":"2013","journal-title":"Res. J. Pharm. Biol. Chem. Sci."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0225","first-page":"263","article-title":"Development evaluation and characterization of surface solid dispersion for solubility and dissolution enhancement of irbesartan","volume":"4","author":"Meka","year":"2012","journal-title":"Int. J. Drug Dev. Res."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0230","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijpharm.2011.01.011","article-title":"Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone\/cyclodextrin complexes","volume":"407","author":"Messner","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0235","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2011.02.008","article-title":"Self-assembly of cyclodextrins: the effect of the guest molecule","volume":"408","author":"Messner","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0240","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijpharm.2011.07.041","article-title":"Self-assembly of cyclodextrin complexes: effect of temperature agitation and media composition on aggregation","volume":"419","author":"Messner","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0245","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1124\/jpet.104.067512","article-title":"Behavior of \u03b1-, \u03b2-, and \u03b3-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier","volume":"310","author":"Monnaert","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0250","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.yrtph.2004.05.008","article-title":"Safety assessment of \u03b3-cyclodextrin","volume":"39","author":"Munro","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0255","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jps.23760","article-title":"Analysis of sartans: a review","volume":"103","author":"Muszalska","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0260","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.carbpol.2012.11.082","article-title":"Spectroscopic investigation on the inclusion complex formation between amisulpride and \u03b3-cyclodextrin","volume":"92","author":"Negi","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0265","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/2231-4040.79799","article-title":"Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan","volume":"2","author":"Patel","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0270","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1021\/jp0688815","article-title":"On the characterization of host\u2013guest complexes: surface tension, calorimetry, and molecular dynamics of cyclodextrins with a non-ionic surfactant","volume":"111","author":"Pineiro","year":"2007","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0275","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.carbpol.2013.10.016","article-title":"Inclusion complex of sulfadimethoxine with cyclodextrins preparation and characterization","volume":"101","author":"Rajendiran","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0280","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/jcis.1998.5776","article-title":"Aggregation behavior of tyloxapol, a nonionic surfactant oligomer, in aqueous solution","volume":"210","author":"Regev","year":"1999","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0285","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0928-0987(03)00199-4","article-title":"Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with \u03b2-cyclodextrin and its sulfobutyl ether derivative in solution and solid state","volume":"20","author":"Ribeiro","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0290","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/jps.2600621232","article-title":"Enhancement of benzalkonium chloride and chlorhexidine acetate activity against Pseudomonas aeruginosa by aromatic alcohols","volume":"62","author":"Richards","year":"1973","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0295","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2415-11-8","article-title":"Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system","volume":"11","author":"Ryan","year":"2011","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0300","first-page":"107","article-title":"Antimicrobial substances in ophthalmic drops","volume":"53","author":"Sklubalova","year":"2004","journal-title":"Ceska Slov. Farm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0305","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.1167\/iovs.11-8178","article-title":"Topical dexamethasone\u2013cyclodextrin microparticle eye drops for diabetic macular edema","volume":"52","author":"Tanito","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0310","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejpb.2012.11.003","article-title":"Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole","volume":"83","author":"Taupitz","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0315","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijpharm.2014.03.035","article-title":"Effect of cyclodextrins and pH on the permeation of tetracaine: supramolecular assemblies and release behavior","volume":"466","author":"Teixeira","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0320","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cis.2013.08.001","article-title":"The formation of host\u2013guest complexes between surfactants and cyclodextrins","volume":"205","author":"Valente","year":"2014","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0325","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0928-0987(99)00068-8","article-title":"Influence of surfactants (present in the dissolution media) on the release behavior of tolbutamide from its inclusion complex with \u03b2-cyclodextrin","volume":"9","author":"Veiga","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0330","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.3390\/molecules17033461","article-title":"Simultaneous analysis of irbesartan and hydrochlorothiazide: an improved HPLC method with the aid of a chemometric protocol","volume":"17","author":"Vujic","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0335","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jcis.2005.11.014","article-title":"Investigation on \u03b3-cyclodextrin nanotube induced by N,N\u2032-diphenylbenzidine molecule","volume":"297","author":"Wu","year":"2006","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0340","first-page":"199","article-title":"The mechanism of ocular hypotensive effect of CS-088, angiotensin II type I receptor blocker, in pigmented rabbit Investigation of central ocular hypotensive effect","volume":"64","author":"Yoshida","year":"2004","journal-title":"Showa Igakkai Zasshi"},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0345","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrd3745","article-title":"Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma","volume":"11","author":"Zhang","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpharm.2014.08.013_bib0350","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3109\/03639045.2011.575379","article-title":"Preparation of stable micron-sized crystalline irbesartan particles for the enhancement of dissolution rate","volume":"37","author":"Zhang","year":"2011","journal-title":"Drug Dev. Ind. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517314005791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517314005791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T06:57:30Z","timestamp":1649919450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517314005791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":70,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0378517314005791"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.08.013","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of \u03b3-cyclodextrin on solubilization and complexation of irbesartan: Influence of pH and excipients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}